NCT02396537View on ClinicalTrials.gov

Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pain
Interventions
DRUG

Lidocaine

Administered intranasally prior to Midazolam administration.

DRUG

Midazolam

Administered to all patients immediately after study drug (Lidocaine or Placebo) administered.

DRUG

0.9% Saline

Administered intranasally prior to Midazolam administration.

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02396537 - Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration | Biotech Hunter | Biotech Hunter